- Home
- QNCX vs ORMP Comparison
QNCX vs ORMP Comparison
Compare QNCX & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QNCX | ORMP |
|---|---|---|
| Founded | 2012 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.5M | 170.3M |
| IPO Year | 2019 | 2010 |
Fundamental Metrics
Financial Performance| Metric | QNCX | ORMP |
|---|---|---|
| Price | $30.32 | $4.78 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 18.4K | ★ 215.0K |
| Earning Date | 04-10-2026 | 05-14-2026 |
| Dividend Yield | N/A | ★ 6.51% |
| EPS Growth | N/A | ★ 412.50 |
| EPS | N/A | ★ 2.76 |
| Revenue | N/A | ★ $2,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $1.80 |
| Revenue Growth | N/A | ★ 49.25 |
| 52 Week Low | $0.08 | $2.09 |
| 52 Week High | $35.41 | $5.47 |
Technical Indicators
Market Signals| Indicator | QNCX | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 49.10 | 49.85 |
| Support Level | $0.82 | $3.91 |
| Resistance Level | $35.38 | $5.10 |
| Average True Range (ATR) | 2.09 | 0.24 |
| MACD | -1.02 | -0.04 |
| Stochastic Oscillator | 8.66 | 7.59 |
Price Performance
Historical ComparisonAbout QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. Its proprietary AIDE technology is an inventive drug/device combination platform that uses an automated process to encapsulate a drug into a patient's own red blood cells. Its Phase 3 asset, eDSP, leverages the AIDE technology to encapsulate DSP into a patient's own red blood cells, and is targeted to treat a rare pediatric neurodegenerative disease, A-T.
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.